World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
79
Citations
21528
World Ranking
17622
National Ranking
8805

Overview

Michael A. Nalesnik is affiliated with the University of Pittsburgh in the United States. Their research focuses primarily on medicine, with significant contributions in epidemiology, oncology, hepatology, pulmonary and respiratory medicine, and molecular biology.

The scientist has concentrated on several key topics throughout their career. These include:

  • Hepatitis B Virus Studies
  • Hepatitis C virus research
  • Liver Disease Diagnosis and Treatment
  • Neuroendocrine Tumor Research Advances
  • Lung Cancer Research Studies
  • Renal Transplantation Outcomes and Treatments
  • Neuroblastoma Research and Treatments

Recent publications by Michael A. Nalesnik highlight diverse areas of medical research and transplantation science. Notable papers include:

  • Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size, 2021, published in Gut
  • Ten years of donor-derived disease: A report of the disease transmission advisory committee, 2020, American Journal of Transplantation
  • Transcriptome and Exome Analyses of Hepatocellular Carcinoma Reveal Patterns to Predict Cancer Recurrence in Liver Transplant Patients, 2021, Hepatology Communications
  • Pten-NOLC1 fusion promotes cancers involving MET and EGFR signalings, 2020, Oncogene
  • Donor derived hepatitis B virus infection: Analysis of the Organ Procurement & Transplantation Network/United Network for Organ Sharing Ad Hoc Disease Transmission Advisory Committee, 2020, Transplant Infectious Disease

They have coauthored multiple works with several frequent collaborators, including:

  • Aatur D. Singhi
  • Silvia Liu
  • Bao-Guo Ren
  • George K. Michalopoulos
  • Marc G. Ghany

Michael A. Nalesnik's work is published in a variety of scientific journals, with multiple papers appearing in:

  • Hepatology Communications
  • UNC Libraries
  • Gastroenterology
  • Gut
  • American Journal of Transplantation

The scope of their research addresses complex issues in liver transplant outcomes, disease transmission, cancer biology, and viral hepatitis, providing insights across several interconnected disciplines within medicine.

Best Publications

  • Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production.

    C L Nastala;H D Edington;T G McKinney;H Tahara

  • Cell migration and chimerism after whole-organ transplantation: The basis of graft acceptance

    Thomas E. Starzl;Anthony J. Demetris;Massimo Trucco;Noriko Murase

  • The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression.

    M A Nalesnik;R Jaffe;T E Starzl;A J Demetris

  • The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation.

    Elsie S. Lee;Joseph Locker;Michael Nalesnik;Jorge Reyes

  • Epstein-barr virus-induced posttransplant lymphoproliferative disorders

    Carlos V. Paya;John J. Fung;Michael A. Nalesnik;Elliott Kieff

  • Tolerogenic immunosuppression for organ transplantation.

    Thomas E Starzl;Noriko Murase;Kareem Abu-Elmagd;Edward A Gray

  • THE FREQUENCY OF EPSTEIN-BARR VIRUS INFECTION AND ASSOCIATED LYMPHOPROLIFERATIVE SYNDROME AFTER TRANSPLANTATION AND ITS MANIFESTATIONS IN CHILDREN

    Monto Ho;Ronald Jaffe;George Miller;Mary Kay Breinig

  • Hepatocellular carcinoma: evaluation with biphasic, contrast-enhanced, helical CT.

    R L Baron;J H Oliver rd;G D Dodd rd;M Nalesnik

  • Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression.

    Armitage Jm;Kormos Rl;Stuart Rs;Fricker Fj

  • Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: A distinct entity?

    Beverly P. Nelson;Michael A. Nalesnik;David W. Bahler;Joseph Locker

  • Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States.

    Elizabeth A. Pomfret;Kenneth Washburn;Christoph Wald;Michael A. Nalesnik

  • Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors.

    Masahiro Shuda;Reety Arora;Hyun Jin Kwun;Huichen Feng

  • Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas

    Jian-Hua Luo;Baoguo Ren;Sergei Keryanov;George C. Tseng

  • The diagnosis and treatment of posttransplant lymphoproliferative disorders.

    Michael A. Nalesnik;Leonard Makowka;Thomas E. Starzl;Thomas E. Starzl

  • Hepatocyte paraffin 1: a monoclonal antibody that reacts with hepatocytes and can be used for differential diagnosis of hepatic tumors.

    Anne E. Wennerberg;Michael A. Nalesnik;William B. Coleman

  • Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience.

    Ashok Jain;Mike Nalesnik;Jorge Reyes;Renu Pokharna

  • Fibrolamellar Hepatocellular Carcinoma: Imaging and Pathologic Findings in 31 Recent Cases

    Tomoaki Ichikawa;Michael P. Federle;Luigi Grazioli;Juan Madariaga

  • Carbon monoxide inhalation protects rat intestinal grafts from ischemia/reperfusion injury.

    Atsunori Nakao;Kei Kimizuka;Donna B. Stolz;Joao Seda Neto

  • Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease.

    Parmjeet S. Randhawa;Ronald Jaffe;Anthony J. Demetris;Michael Nalesnik

  • An Update on Donor-Derived Disease Transmission in Organ Transplantation

    M. G. Ison;M. A. Nalesnik

Frequent Co-Authors

Anthony J. Demetris
Anthony J. Demetris University of Pittsburgh
Thomas E. Starzl
Thomas E. Starzl University of Pittsburgh
Noriko Murase
Noriko Murase University of Pittsburgh
Parmjeet Randhawa
Parmjeet Randhawa University of Pittsburgh
John J. Fung
John J. Fung University of Chicago
George K. Michalopoulos
George K. Michalopoulos University of Pittsburgh
David A. Geller
David A. Geller University of Pittsburgh
Kareem Abu-Elmagd
Kareem Abu-Elmagd Cleveland Clinic
Tong Wu
Tong Wu Chinese Academy of Sciences
Donna B. Stolz
Donna B. Stolz University of Pittsburgh

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in a career in healthcare but not ready to enroll in a traditional medical program, there are flexible alternative pathways available online. For example, online BSN programs for non nurses allow individuals with a degree in another field to pursue nursing without starting from scratch. These programs can help you transition into a meaningful healthcare career quickly.

If you prefer an administrative role, consider enrolling in an online BSN programs for non nurses offer a streamlined route into nursing, while accredited medical billing and coding schools online with financial aid provide a pathway to essential non-clinical roles, often with financial support available to qualifying students.

Some students may prefer an easier admissions process. There are nursing schools that don't require TEAS or HESI, so you can focus on your passion for nursing without test anxiety. Those interested in leadership and management roles in healthcare should look into accelerated healthcare administration degree programs, which can fast-track your entry into this dynamic field.

Best Scientists Citing Michael A. Nalesnik

Trending Scientists